Youcare Pharmaceutical Group Co., Ltd. (688658.SS)
CNY 12.35
(-16.72%)
CNY 12.35
(-16.72%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.31 Billion CNY | 15.03% |
| 2022 | 2.01 Billion CNY | 11.76% |
| 2021 | 1.79 Billion CNY | -3.82% |
| 2020 | 1.87 Billion CNY | -20.12% |
| 2019 | 2.34 Billion CNY | -9.05% |
| 2018 | 2.57 Billion CNY | -7.77% |
| 2017 | 2.79 Billion CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 2.33 Billion CNY | 7.45% |
| 2024 Q1 | 2.46 Billion CNY | 6.5% |
| 2024 Q2 | 2.17 Billion CNY | -11.93% |
| 2023 Q3 | 2.1 Billion CNY | -5.38% |
| 2023 FY | 2.31 Billion CNY | 15.03% |
| 2023 Q4 | 2.31 Billion CNY | 9.8% |
| 2023 Q2 | 2.22 Billion CNY | 2.05% |
| 2023 Q1 | 2.18 Billion CNY | 8.49% |
| 2022 Q3 | 2.01 Billion CNY | 25.75% |
| 2022 Q2 | 1.6 Billion CNY | -2.54% |
| 2022 Q1 | 1.64 Billion CNY | -8.76% |
| 2022 FY | 2.01 Billion CNY | 11.76% |
| 2022 Q4 | 2.01 Billion CNY | -0.04% |
| 2021 Q1 | 1.56 Billion CNY | -16.59% |
| 2021 Q2 | 1.47 Billion CNY | -5.31% |
| 2021 FY | 1.79 Billion CNY | -3.82% |
| 2021 Q3 | 1.42 Billion CNY | -3.71% |
| 2021 Q4 | 1.79 Billion CNY | 26.47% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q4 | 1.87 Billion CNY | 14.72% |
| 2020 Q3 | 1.63 Billion CNY | -13.3% |
| 2020 Q2 | 1.88 Billion CNY | 0.0% |
| 2020 FY | 1.87 Billion CNY | -20.12% |
| 2019 FY | 2.34 Billion CNY | -9.05% |
| 2019 Q4 | 2.34 Billion CNY | 0.0% |
| 2018 FY | 2.57 Billion CNY | -7.77% |
| 2017 FY | 2.79 Billion CNY | 0.0% |